Testosterone isocaproate
A mid-length testosterone ester that only ever appears as one component of a blend such as Sustanon.
Medications & hormones
Research records
Historical source snapshot. Not freshly verified, not a recommendation. Study findings, community accounts and app defaults are not interchangeable.
Publication suitability · 2026-10-15: Historical reference only; not a clinical verification. Clinical, regulatory, efficacy, safety and dose claims are not independently established by this review.
Testosterone isocaproate
A mid-length testosterone ester that only ever appears as one component of a blend such as Sustanon.
Evidence category: Reference only. This describes the source category, not approval or certainty.
Regulatory statement in source: Not separately recorded; do not infer approval from the evidence category.
Testosterone isocaproate is a mid-length testosterone ester used exclusively as one of the four esters in Sustanon-type blends. No dedicated human pharmacokinetic study of this ester in isolation was located in the literature search performed for this entry; every published pharmacokinetic figure for isocaproate is confounded with the other esters (propionate, phenylpropionate, decanoate) it is always co-administered with in the same injection, so no single-compound half-life can honestly be reported here.
Benefits reported in the imported source
- Contributes a mid-length release phase to blended esters such as Sustanon.
Risks and limits
- No dedicated single-compound human pharmacokinetic study exists for this ester alone; published data is confounded with the other esters in the same blend.
- Never marketed or studied as a standalone injectable.
Source bottom line: A mid-length testosterone ester known only as one component of blends such as Sustanon; no half-life for the isolated compound has been established.
Uncertainty: Reference information only. Not medical advice.
Study protocols — reports, not instructions
No study protocol recorded in this snapshot. This does not establish that no study exists.
Community and practice descriptions
Accounts of a practice are not evidence of safety or effectiveness. Words such as “standard”, “safe” or “recommended” describe the source account, not verified consensus or this wiki’s advice. Commercial and self-published citations are retained for traceability, not vendor endorsement or independent clinical corroboration.
No community description recorded. This entry has no final B-82 outcome record; it is not a researched-empty finding.
Pharmacokinetic context
No half-life recorded in this source snapshot. No value has been inferred.
Source references
Snapshot provenance
Source ID: catalog:hormone:testosterone-isocaproate. Commit: adc7684614f9439b41d91a3312b62e7982c7e20e. Review state: historical-not-reverified. Authored links are retained separately from the canonical evidence links in the public data. App templates/defaults and rejected drafts are archived, not deployed.
Related entries and components
None listed.